An observational study in Conditions, Infections and Heart Failure, sponsored by OSF Healthcare System. Enrolling by invitation at 1 site in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-03-17.
Sponsored by OSF Healthcare System · Observational
The purpose of this study is to examine the implementation, intervention effectiveness, and dissemination of a digital acute care delivery model for improving selected health outcomes in the Hospital at Home population.
The investigators will conduct a mixed-methods quasi-experimental research study that will explore the effectiveness of the Hospital at home programs using qualitative interviews and quantitative data as a means to also conduct a process evaluation related to the implementation and efficacy of Hospital at Home programs. The purpose of this pragmatic study is to inform scalability beyond the initial site for implementation within a large healthcare system with a diverse patient population located in various communities, including rural and urban locations.
156 studies on the registry are indexed under Bronchitis; 21 are open to participants now.
This study's planned enrollment of 9,654 is above the median of 1,000 across 45 observational studies indexed under Bronchitis.
Browse Bronchitis studies →OSF Healthcare System is the lead sponsor of 23 studies on the registry; 1 is open to participants now.
Compared within Bronchitis, this study's primary condition as ClinicalTrials.gg classifies it; the registry's first condition term is Disease. The counts are of registry records indexed under each term, refreshed daily. How we classify →
The study population will consist of individuals who are receiving care in the hospital at home program and those who are hospitalized but choose to receive hospital care in the home setting after a short period in the hospital. All those enrolled in the Hospital at Home Program will be strategically identified and used as the population for the quantitative and qualitative portions of the study.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Patient caregiver inclusion criteria: (not required for patient participation):
Clinician or stakeholder inclusion criteria:
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Chronic obstructive pulmonary disease: long-term lung disease that makes it hard to breathe out, including emphysema and chronic bronchitis.
COPD
Chronic obstructive pulmonary disease: long-term lung disease that makes it hard to breathe out, including emphysema and chronic bronchitis.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
The population for this study includes adult patients who are acutely ill and presenting to the emergency room, and are discharged to their home for hospital-level care in the home setting. The patients in this cohort may also include those who are discharged from the hospital early, but receive hospital-level care in the home setting.
Other: Digital Care Solution as supportive personalized care
The population for this study includes adult patients who are acutely ill and presenting to the emergency room who elect not to be discharged, choose to be cared for in the hospital setting.
Other: Traditional Hospital Level Care
Patients will need to meet screening and inclusion criteria at time of enrollment. As a pragmatic study, researchers will not determine criteria or management of care aspects for patients.
Also known as: Traditional Hospital Level Care
Patients will be cared for in the inpatient setting for management of diseases that meet screening and inclusion criteria at time of enrollment for hospital at home. As a pragmatic study, researchers will not determine criteria or management of care aspects for patients.
Composite of all-cause mortality for patients admitted to digital hospital
Total number of deaths over total number of patients admitted to the digital hospital.
Time frame: Up to 30 days, (date of death from any cause, whichever came first, assessed up to 30 days)
30-day readmission rate
Number of 30-day readmissions as defined by Organization using preset criteria
Time frame: Up to 30 days (date of readmission from any cause, whichever came first, assessed up to 30 days)
Patient Satisfaction at discharge
1-item measure: I would recommend this \[insert program name\] to others, assessed at discharge name\] to others.
Time frame: up to 1 week
Patient Perception of Digital Care at discharge
Results of Digital Care - Likert Scale (very satisfied to very dissatisfied)
Time frame: up to 1 week
Escalations (for management and treatment of early decompensation)
percentage of patients escalated over total hospital digital encounters
Time frame: up to 2 weeks
Unplanned readmission within 30-days of discharge
Number of 30-day readmissions over total number of discharges
Time frame: up to 30 days
Length of Stay
Day of admission to day of discharge, assessed up to 2 months
Time frame: assessed up to 2 weeks
Number of participants with Hospital Acquired Infections
Number of hospital acquired infections reported (CAUTI, CLABSI, etc.)
Time frame: assessed up to 1 week
Number of participants with discharge disposition at time of discharge as one other than home
Exploratory - discharge disposition other than patient's home
Time frame: assessed up to 8 weeks
Qualitative interviews
Interviews with patients, caregivers, and hospital and digital health clinicians, workers, ancillary services
Time frame: through study completion, an average of 2 years
Number of readmissions between discharge and during next 6 months.
Exploratory
Time frame: Up to 6 months (Re-admission from any cause, assessed up to 6 months)
Number of Emergency Department visits after discharge for any cause
Exploratory
Time frame: assessed up to 6 months
Number of visits in home by provider, clinician, and worker type
Exploratory
Time frame: assessed up to 2 months
EuroQol-5D-5L
5 items self-reported and visual analogue scale, 0-100, where 100 is the best imaginable health today
Time frame: up to 2 months, assessed twice in this period
Program Implementation and Evaluation Measure
15-item measure to assess health care professionals' perceptions of digital care, measured using a Likert scale of 1 to 5, with 1= Not at all, 2=Slightly, 3=Moderately, 4=Very Much, and 5= Entirely. Includes three open-ended questions
Time frame: at baseline and 1-year following implementation
Montgomery caregiver burden inventory measure
11-items to assess objective, relationship, and stress for caregivers. A 5-point response set ranging from 1 (not at all) to 5 (a great deal)
Time frame: at approximately 48 hours following admission and at 31-days post-discharge
Clinical Sustainability Assessment Tool
Exploratory - measures organizational and contextual factors for sustainability of a project or initiative. Uses a 7-point Likert scale where 1= to little or no extent to 7=to a great extent. Also includes response option of N/A - not able to answer.
Time frame: at baseline and 1-year following implementation
Plan to share: No
Started Aug 2023 (actual). Primary completion is estimated for Dec 2026, 40 months after the start.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
No contact was published for this record. The registry link below has the sponsor’s details.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
OSF Healthcare System